Performance characteristics and operational feasibility assessment of a CRISPR based tata MD CHECK diagnostic test for SARS-CoV-2 (COVID-19).

Autor: Shenai S; FIND, New Delhi, India., Nataraj G; Department of Microbiology, Seth GSMC, & KEM Hospital, Mumbai, Maharashtra, India., Jinwal M; Department of Microbiology, Seth GSMC, & KEM Hospital, Mumbai, Maharashtra, India., Thekke Purakkal AS; FIND, New Delhi, India., Sen R; FIND, New Delhi, India., Ingole N; Department of Microbiology, Seth GSMC, & KEM Hospital, Mumbai, Maharashtra, India., Mathure T; Department of Microbiology, Seth GSMC, & KEM Hospital, Mumbai, Maharashtra, India., Sarin S; FIND, New Delhi, India., Chadha SS; FIND, New Delhi, India.

Publikováno v: PloS one [PLoS One] 2023 Sep 14; Vol. 18 (9), pp. e0291269. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).

Implementation of a tuberculosis elimination project, India 2018-2019.

Autor: Kalra A; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., ThekkePurakkal AS; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., Rao R; Central TB Division, Ministry of Health and Family Welfare, New Delhi, India., Parija D; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., Ghule V; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., Lone A; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., Showket T; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India., Joshi RP; Central TB Division, Ministry of Health and Family Welfare, New Delhi, India., Sarin S; FIND, Geneva, Switzerland., Chadha SS; FIND, Flat No. 8, 9th Floor, Vijaya Building, 17 Barakhamba Road, New Delhi110001, India.

Publikováno v: Bulletin of the World Health Organization [Bull World Health Organ] 2023 Mar 01; Vol. 101 (3), pp. 179-190. Date of Electronic Publication: 2023 Jan 18.

One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries.

Autor: Klinton JS; McGill International TB Centre, Montreal, Canada.; TBPPM Learning Network, Canada., Heitkamp P; McGill International TB Centre, Montreal, Canada.; TBPPM Learning Network, Canada., Rashid A; Mercy Corps, Pakistan., Faleye BO; SHOPS Plus, Abt Associates, Nigeria., Win Htat H; Population Services International (PSI), Myanmar., Hussain H; Interactive Research and Development (IRD), Singapore., Syed I; FHI 360, Indonesia., Farough K; Greenstar Social Marketing, Pakistan., Mortera L; FHI 360, Philippines., Moh Lwin M; Population Services International (PSI), Myanmar., Jha N; World Health Partners (WHP), India., Ananthakrishnan R; Resource Group for Education and Advocacy for Community Health (REACH), India., Mahfuza R; BRAC, Bangladesh., Chadha SS; Foundation for Innovative New Diagnostics (FIND), India., Banu S; Programme on Emerging Infections, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh., Mannan S; Clinton Health Access Initiative (CHAI), India., Vijayan S; PATH, Delhi, India., Ahmed S; Programme on Emerging Infections, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh., Ali T; Institute of Human Virology (IHVN), Nigeria., Oga-Omenka C; McGill International TB Centre, Montreal, Canada., Kaur M; McGill International TB Centre, Montreal, Canada., Singh U; McGill International TB Centre, Montreal, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, Canada., Wells WA; US Agency for International Development (USAID), Washington, D.C., United States of America., Stallworthy G; Bill and Melinda Gates Foundation, Seattle, WA, United States of America., Dias HMY; Global TB Programme, World Health Organization (WHO), Switzerland., Pai M; McGill International TB Centre, Montreal, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Publikováno v: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2021 Dec; Vol. 25, pp. 100277. Date of Electronic Publication: 2021 Sep 16.

Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape.

Autor: Monedero-Recuero I; Unitat d'Atenció Territorial a la Cronicitat i Complexitat Garraf, Institut Català de la Salut, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain; TB-HIV Department, International Union against Tuberculosis and Lung Disease, Paris, France. Electronic address: imonedero@theunion.org., Gegia M; Prevention, Diagnosis, Treatment, Care and Innovation Unit, Global TB Programme, World Health Organization, Geneva, Switzerland., Wares DF; KNCV Tuberculosis Foundation, The Hague, The Netherlands., Chadha SS; Foundation for Innovative New Diagnostics (FIND), New Dehli, India., Mirzayev F; Prevention, Diagnosis, Treatment, Care and Innovation Unit, Global TB Programme, World Health Organization, Geneva, Switzerland.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Jul; Vol. 108, pp. 557-567. Date of Electronic Publication: 2021 Jun 15.

Determination of Direct and Indirect Costs Incurred by Tuberculosis Patients During Diagnosis and Treatment in Urban Areas of South Gujarat: A Mixed Method Approach.

Autor: Buch, Rutu¹, Damor, Rahul¹ dr_rahul_damor@yahoo.co.in, Kosambiya, J. K.¹

Publikováno v: Indian Journal of Community Medicine. Nov/Dec2024, Vol. 49 Issue 6, p873-878. 6p.